4//SEC Filing
Turner Heather D 4
Accession 0001209191-18-009413
CIK 0001604464other
Filed
Feb 11, 7:00 PM ET
Accepted
Feb 12, 9:00 PM ET
Size
14.9 KB
Accession
0001209191-18-009413
Insider Transaction Report
Form 4
Turner Heather D
VP, General Counsel & Sec.
Transactions
- Sale
Common Stock
2018-02-09$38.63/sh−600$23,178→ 72,389 total - Sale
Common Stock
2018-02-09$39.66/sh−733$29,071→ 71,656 total - Sale
Common Stock
2018-02-09$36.63/sh−4,596$168,351→ 77,112 total - Sale
Common Stock
2018-02-09$37.38/sh−4,123$154,118→ 72,989 total - Sale
Common Stock
2018-02-09$40.62/sh−600$24,372→ 71,056 total - Sale
Common Stock
2018-02-09$41.69/sh−1,562$65,120→ 69,494 total
Footnotes (7)
- [F1]Transaction pursuant to Rule 10b5-1 Plan adopted September 23, 2016.
- [F2]The price in Column 4 is a weighted average sale price. The prices actually received ranged from $36.00 to $37.00. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F3]The price in Column 4 is a weighted average sale price. The prices actually received ranged from $37.05 to $38.05. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F4]The price in Column 4 is a weighted average sale price. The prices actually received ranged from $38.10 to $39.05. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F5]The price in Column 4 is a weighted average sale price. The prices actually received ranged from $39.15 to $39.95. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F6]The price in Column 4 is a weighted average sale price. The prices actually received ranged from $40.20 to $41.05. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F7]The price in Column 4 is a weighted average sale price. The prices actually received ranged from $41.35 to $41.80. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
Documents
Issuer
Atara Biotherapeutics, Inc.
CIK 0001604464
Entity typeother
Related Parties
1- filerCIK 0001403571
Filing Metadata
- Form type
- 4
- Filed
- Feb 11, 7:00 PM ET
- Accepted
- Feb 12, 9:00 PM ET
- Size
- 14.9 KB